INTRODUCTION
Pfizer is a pharmaceutical company based in New York. The company was founded in 1849 and has been on the drug production market for a long time, however, it was only the creation of the covid 19 vaccine that made the company one of the largest giants in this industry. The company created the vaccine in collaboration with BioNtech and thanks to close support this vaccine achieved very high scores (about 95 per cent) on effectiveness against covid 19.
WALLSTREET VS PFIZER
The company, after all, is not appreciated on the WallStreet stock exchange, where the company’s shares do not grow as high as other companies producing vaccines. Indeed, the company’s profits were not so high when it comes to the stock exchanges, but the company BioNtech, closely cooperating with Pfizer, gained a lot, whose shares went up by 258 per cent according to the latest stock exchange reports. Because covid has become a disease similar to the flu, in terms of its frequency of occurrence during the year, the company can achieve more and more profits in the coming years because the production of the vaccine is increasing and the effectiveness of Pfizer is often much higher than that of other vaccines, which is why it is willingly chosen (the exception is modern, which has very similar results, and AstraZeneca, which, despite its directly lower effectiveness, can do better in the long term than Pfizer). For example, Johnson and Johnson produces vaccines with much lower effectiveness than Pfizer, which means that much fewer countries decide to buy them. Also, after 3 vaccinations, the Pfizer vaccine immunizes humans against a new variant of coronavirus, i.e. omicron. Research has shown that this type of coronavirus is not as dangerous as some of its earlier varieties.
/cloudfront-us-east-1.images.arcpublishing.com/gray/77SQLW2NKFELNKPALHBBLJA6NU.jpg)
PAXLOVID
Pfizer has also recently created a new anti-viral pill (C23H32F3N5O4). Paxlovid is an antiviral drug that (blocks the activity of an enzyme that the virus needs to multiply. levels that affect the virus). Paxlovid administered 3 days after the onset of coronavirus symptoms showed very high effectiveness of around 90 per cent, which makes it the most effective known drug, which will probably be introduced to the market after all research and will become widely available in the coming years.
WHY IT IS BAD?
But why is it not so good? Currently, only 2 companies are actually in the race for vaccine effectiveness. Moderna and Pfizer do not have to worry too much about the competition of AstraZeneca, which due to their dubious poor start, poor results and a large number of critical negative symptoms caused by its administration, were far behind, as well as Johnson and Jonhson, who voluntarily withdraws from the production of vaccines, not to mention already about Sputnik which is more of a meme than an actually successful vaccine. Moderna and Pfizer, in cooperation with BioNtech, will take over the vaccine market in 100 per cent in some time, since they are private companies and they will be able to significantly increase the price of their vaccines. History has shown that the existence of a monopoly or a duopoly on the market is never beneficial to the consumer and can cause serious problems with the price of the vaccine. The entry threshold for the production of a vaccine is very high, therefore competitive companies that want to compete with the above-mentioned companies may not be able to cope with this market.
CONCLUSION
In conclusion, we are pleased with the enormous development of knowledge about coronavirus that allows us to deal with it, but it may be worrying what will happen when 2 companies from one country take over the vaccine market around the world.